Bardelli Lab
@bardellilab
Clonal evolution and drug resistance: from cancer avatars to liquid biopsies.
ID: 1205436454060675072
https://www.ifom.eu/it/ricerca-cancro/ricerca-lab/ricerca-lab-bardelli.php 13-12-2019 10:37:27
101 Tweet
757 Followers
161 Following
Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers! 💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER 🗓️19-20 June 🇮🇹 Trento ⏳ Still few days to register, deadline: 31/05👉 lnkd.in/etYSdNMX ESOncology recommended event
Great start of day 2 at #EACR2023 with drug resistance session, wonderful talk by mariangela russo from Bardelli Lab on innovative concepts in cancer persisters evolution and new approaches to eradicate them exploiting DNA damage and DDR inhibitors! Exciting science EACR
Live from #EACR2023: Joint EACR-SIC Italian Cancer Society Symposium: ‘Spatial Transcriptomics’ chaired by Nicola Normanno & Chiara AmbrogioLab 👏
Great lecture of Alberto Bardelli Bardelli Lab yesterday at EACR meeting explaining how targeting of MLH1 and temozolamide treatment can engage #immunotherapy response in #coloncancer
Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on Nature Reviews Cancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives Persisters: rdcu.be/dSJp4
A great overview/update of this burgeoning field! Still a lot of unanswered questions, but exciting time ahead! Happy we could contribute to this field and comprehensive overview. Thanks to Bardelli Lab for taking the lead.
📢This week in Nature Reviews Cancer, a joint effort by many groups led by the Bardelli Lab on #Cancer Persister cells. 🙌🏻It’s been a pleasure to contribute to this roadmap. ➡️rdcu.be/dSJp4
Excellent review from mariangela russo Bardelli Lab discussing our current understanding of drug-tolerant persister cells in cancer. nature.com/articles/s4156…